Literature DB >> 7066042

Clinical and pathogenetic implications of histopathology in childhood polydermatomyositis.

W E Crowe, K E Bove, J E Levinson, P K Hilton.   

Abstract

Childhood dermatomyositis is a distinct subset of dermatomyositis with highly variable outcome. We reviewed our experience with 29 patients observed over 22 years and attempted to correlate tissue manifestation with outcome. Distinctive vascular lesions included non-necrotizing vasculitis and a unique spectrum of endovascular injury producing temporary or permanent occlusion of small arteries and capillaries. Vessels with noninflammatory endovasculopathy were often reactive with fluorescein-conjugated antisera to IgM, C3d, and/or fibrin. Lesions linked to endovascular injury include infarction, zonal myopathy, and loss of capillary network. We were able to identify half of the children destined to have persistent morbidity on the basis of severity of vasculopathy in pretreatment muscle-biopsy specimens. Our observations support a central role for endothelial cell injury in the pathogenesis of childhood dermatomyositis, suggest a basis for assessing the efficacy of therapy, and provide a focus for investigation of basic mechanisms.

Entities:  

Mesh:

Year:  1982        PMID: 7066042     DOI: 10.1002/art.1780250203

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  30 in total

1.  Late-onset gastrointestinal pain in juvenile dermatomyositis as a manifestation of ischemic ulceration from chronic endarteropathy.

Authors:  Gulnara Mamyrova; David E Kleiner; Laura James-Newton; Bracha Shaham; Frederick W Miller; Lisa G Rider
Journal:  Arthritis Rheum       Date:  2007-06-15

Review 2.  Clinical features, pathogenesis and treatment of juvenile and adult dermatomyositis.

Authors:  Angela B Robinson; Ann M Reed
Journal:  Nat Rev Rheumatol       Date:  2011-09-27       Impact factor: 20.543

3.  Multiple target autoantigens on endothelial cells identified in juvenile dermatomyositis using proteomics.

Authors:  Rie Karasawa; Mayumi Tamaki; Toshiko Sato; Megumi Tanaka; Makiko Nawa; Kazuo Yudoh; James N Jarvis
Journal:  Rheumatology (Oxford)       Date:  2018-04-01       Impact factor: 7.580

Review 4.  [Juvenile dermatomyositis].

Authors:  F Dressler; H-I Huppertz
Journal:  Z Rheumatol       Date:  2006-11       Impact factor: 1.372

5.  Acute acalculous cholecystitis in a patient with juvenile dermatomyositis.

Authors:  Bruno Fernandes Sanches; Teresa Martins; Maria José Santos; Paula Azeredo
Journal:  BMJ Case Rep       Date:  2014-09-19

Review 6.  Treatment of Juvenile Dermatomyositis: An Update.

Authors:  Charalampia Papadopoulou; Lucy R Wedderburn
Journal:  Paediatr Drugs       Date:  2017-10       Impact factor: 3.022

7.  Connection of atopic disease in Japanese patients with juvenile dermatomyositis based on serum IgE levels.

Authors:  T Ishida; M Ohashi; Y Matsumoto; J Morikawa; R Sasaki
Journal:  Clin Rheumatol       Date:  1993-03       Impact factor: 2.980

Review 8.  Laboratory evaluation of the inflammatory myopathies.

Authors:  L G Rider; F W Miller
Journal:  Clin Diagn Lab Immunol       Date:  1995-01

Review 9.  Connective Tissue Disorder-Associated Vasculitis.

Authors:  Aman Sharma; Aadhaar Dhooria; Ashish Aggarwal; Manish Rathi; Vinod Chandran
Journal:  Curr Rheumatol Rep       Date:  2016-06       Impact factor: 4.592

10.  Cytokine gene polymorphisms as risk and severity factors for juvenile dermatomyositis.

Authors:  Gulnara Mamyrova; Terrance P O'Hanlon; Laura Sillers; Karen Malley; Laura James-Newton; Christina G Parks; Glinda S Cooper; Janardan P Pandey; Frederick W Miller; Lisa G Rider
Journal:  Arthritis Rheum       Date:  2008-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.